Erythropoietin dampens injury-induced microglial motility

2015 | journal article

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Erythropoietin dampens injury-induced microglial motility​
Mitkovski, M.; Dahm, L. ; Heinrich, R. ; Monnheimer, M.; Gerhart, S. ; Stegmüller, J.   & Hanisch, U.-K.  et al.​ (2015) 
Journal of Cerebral Blood Flow and Metabolism35(8) pp. 1233​-1236​.​ DOI: https://doi.org/10.1038/jcbfm.2015.100 

Documents & Media

9.full.pdf1.04 MBAdobe PDF

License

Published Version

Attribution-NonCommercial-NoDerivs 4.0 CC BY-NC-ND 4.0

Details

Authors
Mitkovski, Miso; Dahm, Liane ; Heinrich, Ralf ; Monnheimer, Mathieu; Gerhart, Simone ; Stegmüller, Judith ; Hanisch, Uwe-Karsten ; Nave, Klaus-Armin ; Ehrenreich, Hannelore 
Abstract
Traumatic brain injury causes progressive brain atrophy and cognitive decline. Surprisingly, an early treatment with erythropoietin (EPO) prevents these consequences of secondary neurodegeneration, but the mechanisms have remained obscure. Here we show by advanced imaging and innovative analytical tools that recombinant human EPO, a clinically established and neuroprotective growth factor, dampens microglial activity, as visualized also in vivo by a strongly attenuated injury-induced cellular motility.
Issue Date
2015
Journal
Journal of Cerebral Blood Flow and Metabolism 
ISSN
0271-678X
Language
English

Reference

Citations


Social Media